Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients

NCT00550459 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyponatremia

Interventions

DRUG: Tolvaptan
DRUG: Placebo

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Collaborators

[object Object]